Could a quick brain zap ease Long-Term nerve pain?
NCT ID NCT07650526
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 5 times
Summary
This study tests two non-invasive brain stimulation techniques—standard rTMS and a faster version called aiTBS—against a sham (fake) treatment in 30 adults with chronic neuropathic pain lasting at least 6 months. Participants receive both active and sham treatments in a random order, with a washout period in between. The goal is to see if these methods reduce pain and to find predictors of who might benefit most.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- transcranial magnetic stimulation (TMS) - a non-invasive device that uses magnetic pulses to stimulate the brain
- What this could lead to
- If successful, this could offer a faster, more convenient non-drug option for managing chronic neuropathic pain.
- What could go wrong
- This is a small early-stage trial with only 30 participants. The effects may be modest or not last long, and not everyone may respond.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC NEUROPATHIC PAIN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hopital Ambroise-Paré INSERM U987, 9 Av. Charles de Gaulle
RECRUITINGBoulogne-Billancourt, Île-de-France Region, 92100, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a tiny dose of naltrexone ease HIV nerve pain without opioids?
- Magnetic pulses to the brain may ease stubborn nerve pain
- Brain zaps may ease stubborn back pain without drugs
- Ecstasy could ease severe nerve pain in new pilot trial
- Can a virtual stroll soothe spinal cord pain?
- Gene therapy targets chronic nerve pain in new trial